HTFL (HeartFlow) Research & Development: $72.6 Mil (TTM As of Mar. 2026)


HTFL HeartFlow Inc HTFL
12 GF Score
Price $29.33
! 4 Warning Signs
View Full Analysis

What is HeartFlow Research & Development?

HeartFlow HTFL -15.83% 12 Research & Development is $72.6 Mil as of Mar. 2026. GuruFocus rates HTFL with a GF Score™ of 12/100. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. HeartFlow's Research & Development for the three months ended in Mar. 2026 was $21.6 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $72.6 Mil.

HeartFlow  (NAS:HTFL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

HeartFlow Research & Development Related Terms

HeartFlow Research & Development Historical Data

* Premium members only.

The historical data trend for HeartFlow's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeartFlow Research & Development Chart

HeartFlow Annual Data
Trend Dec23 Dec24 Dec25
Research & Development
35.85 43.52 64.92

HeartFlow Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.92 15.03 17.30 18.67 21.62
HTFL
12GF Score
HeartFlow Inc HTFL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HeartFlow Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $72.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $72.6 Mil mean?
HeartFlow (HTFL) has a Research & Development of $72.6 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on HeartFlow and its competitors.
Is HeartFlow's Research & Development too high?
HeartFlow's current Research & Development is $72.6 Mil. Overall, HeartFlow has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does HeartFlow's Research & Development compare to PRVA and WAY?
HeartFlow's Research & Development of $72.6 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on HeartFlow and its competitors. HeartFlow's current Research & Development is $72.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartFlow stock overvalued right now?
HeartFlow (HTFL) has a current Research & Development of $72.6 Mil. The current Research & Development is $72.6 Mil. HeartFlow's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For HeartFlow (HTFL), the current Research & Development is $72.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HeartFlow Business Description

Address 331 East Evelyn Avenue, Mountain View, CA, USA, 94041
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
12GF Score

Get the complete analysis for HTFL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.33
Price